What vaccines are recommended for adults aged 60 years and older living in India?

Vaccine Recommendations for Elderly in India

For adults aged 60 years and older in India, prioritize annual influenza vaccination, pneumococcal vaccination (PCV13 or PCV20 followed by PPSV23), recombinant zoster vaccine (Shingrix), and tetanus-diphtheria-pertussis (Tdap) boosters every 10 years, with additional consideration for hepatitis B and COVID-19 vaccines based on individual risk factors.

Core Vaccines for Adults ≥60 Years

Influenza Vaccine

• Administer annually using inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) 1, 2
• For adults ≥65 years, high-dose quadrivalent or adjuvanted formulations provide superior protection 3
• Never use live attenuated influenza vaccine (LAIV) in this age group 1

Pneumococcal Vaccination

This is critical given India bears 23% of the global community-acquired pneumonia burden 4. The vaccination strategy depends on prior vaccination history:

• For vaccine-naive adults ≥60 years:

  • Give PCV20 as a single dose, OR
  • Give PCV15 followed by PPSV23 at least 8 weeks later 5, 6

• If previously received PPSV23 only:

  • Give PCV13, PCV15, or PCV20 at least 1 year after the last PPSV23 dose 2

• Revaccination with PPSV23:

  • If given before age 65, administer a second dose at age ≥65 years, at least 5 years after the first PPSV23 2

Recent phase 3 data from India demonstrates PCV20 elicits robust immune responses across all 20 serotypes with excellent tolerability in Indian adults 7.

Herpes Zoster (Shingles) Vaccine

• Recombinant zoster vaccine (Shingrix) is strongly recommended for all adults ≥50 years 2
• Administer as a 2-dose series:
  • Standard schedule: 2-6 months apart
  • For immunocompromised: 4-8 weeks apart 3
• This has Grade 1 evidence (highest quality) for effectiveness 2
• Give even if previously received live zoster vaccine (Zostavax), waiting at least 2 months after the live vaccine 8

Tetanus-Diphtheria-Pertussis (Tdap)

• One dose of Tdap if not previously received as an adult 1, 5
• Follow with Td or Tdap booster every 10 years 2, 5

Additional Vaccines Based on Risk Factors

Hepatitis B

• For adults 60-64 years: Recommended universally 2
• For adults ≥65 years: Administer based on risk factors including diabetes, chronic liver disease, end-stage renal disease, or potential blood exposure 2
• Use high-antigen formulation (40 mcg) in 3-dose series at 0,1, and 6 months (Recombivax HB) or 4-dose series at 0,1,2, and 6 months (Engerix-B) 5

COVID-19

• Follow current CDC/ICMR recommendations for immunocompromised individuals 2, 5
• Administer boosters as recommended, regardless of timing with other medications 3

Respiratory Syncytial Virus (RSV)

• For adults ≥75 years: Single dose recommended universally 6
• For adults 60-74 years: Consider if chronic heart/lung disease, diabetes, chronic kidney disease, or immunocompromising conditions present 8, 6
• Options include Abrysvo (Pfizer) or Arexvy (GlaxoSmithKline) 3

Critical Implementation Considerations for India

Addressing India-Specific Barriers

The evidence reveals over 80% of Indian adults are unaware of available vaccines 4, and influenza vaccine uptake is ≤2% in adults ≥45 years 9. This represents a massive gap requiring:

• Establishment of dedicated adult vaccination centers 10
• Active engagement of pharmacists, nurses, and community health workers 10, 9
• Integration with chronic disease management programs, particularly for diabetes and cardiovascular disease 11

Timing and Coadministration

• Vaccines can be given simultaneously on the same day at different injection sites 5
• Exception: Separate PCV15 and PPSV23 by at least 8 weeks 5
• No waiting period needed between different vaccines given on separate days 5

Special Populations

For adults with diabetes, chronic lung disease, heart disease, or chronic kidney disease:

• All core vaccines listed above are indicated 2, 12
• Pneumococcal vaccination is particularly critical given increased risk of invasive disease 12, 4

For immunocompromised adults (including those on immunosuppressive therapy):

• Avoid live vaccines entirely 8
• Administer inactivated vaccines, though responses may be blunted 8
• Consider additional doses or higher antigen content formulations 5

Common Pitfalls to Avoid

1. Do not delay vaccination waiting for "optimal" timing—vaccinate at any healthcare encounter 3
2. Do not assume birth before 1957 confers measles/mumps immunity in healthcare workers or immunocompromised individuals 1
3. Do not give live zoster vaccine (Zostavax)—recombinant vaccine (Shingrix) is superior and preferred 2
4. Do not skip pneumococcal vaccination assuming childhood vaccination provides lifelong protection—adults need age-appropriate formulations 4
5. Do not withhold vaccines during stable chronic disease—these patients benefit most from vaccination 1, 12

The evidence strongly supports that vaccination in older Indian adults is severely underutilized 11, 13, 14, representing a critical missed opportunity to reduce morbidity, mortality, and healthcare costs in this rapidly growing demographic that will comprise 27% of India's population by 2036 11.